TOPIC

/ company

GlaxoSmithKline

The London-based multinational drugmaker, also known as GSK, supplies key products such as vaccines in China, as well as drugs for lung disease and cancer. In 2013, the company was targeted by Chinese authorities over alleged corruption, price-fixing and quality controls.

Chairman / President

Jonathan Symonds

CEO / Managing Director

Dame Emma Natasha Walmsley

CFO / Finance Director

Julie Brown

Industry

Pharmaceutical

Website

gsk.com

Headquarters address

79 New Oxford Street, London, WC1A 1DG, United Kingdom

Stock Code

NYSE:GSK
LSE:GSK

Year founded

2000

Pfizer, a leading global research‑based pharmaceutical and biotechnology company, is among the biggest names in the latest cohort. Photo: Reuters

Hong Kong economy

Which global firms are being attracted by Hong Kong’s strategic enterprise scheme?

The South China Morning Post examines 22 firms opening or expanding in the city, with HK$73 billion in investment and 25,000 jobs expected.

21 Apr 2026 - 9:30AM

China’s crackdowns

China charges former AstraZeneca executive – a sign of the times?

13 Feb 2026 - 8:00PM

Made in China 2025

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

8 Jan 2026 - 8:30AM

China economy

Opinion | How China engineered the rapid rise of its drug innovation industry

A market once dominated by generics is now an AI-powered pharmaceutical hub drawing billion-dollar investments from the likes of Pfizer and GSK.

4 Dec 2025 - 10:51AMvideocam

A worker checks the position of a feeding tray in a pharmaceutical manufacturing facility at the Hengrui Biomedical Industrial Park in Lianyungang in Jiangsu province, on December 13, 2021. Photo: Getty Images

Hong Kong economy

Letters | How Hong Kong can help Chinese drug makers go global

Readers discuss opportunities from medical innovation, tech standards in Hong Kong, and how to stop people treating corals like inanimate objects.

27 Oct 2025 - 11:30AM

Hong Kong economy

Digital IP protector from US among 18 firms expanding in Hong Kong under OASES

Vobile among 18 new strategic enterprises that OASES has brought to city.

9 Oct 2025 - 10:22PM

Hong Kong healthcare and hospitals

Hong Kong to launch collaborative study on long-term effects of shingles vaccine

Study by clinical trial institute, University of Hong Kong and drug giant GlaxoSmithKline will assess potential of heart and dementia protection.

9 Sep 2025 - 5:55PM

Memorandum of understanding signing ceremony between the University of Hong Kong,
GlaxoSmithKline and the Greater Bay Area International Clinical Trial Institute for a study to examine the long-term health effects of the shingles vaccine. Photo: Sun Yeung

Biomedicine: Companies

China’s Jiangsu Hengrui signs licensing deal with Braveheart Bio for heart drug

The licensing deal for the HRS-1893 innovative drug could fetch as much as US$1.01 billion in milestone payments.

5 Sep 2025 - 4:20PM

Biomedicine: Companies

Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits

Novel drug roll-outs and revenue from licensing buoy results.

18 Aug 2025 - 7:30AM

Biomedicine: Companies

Opinion | Biotech successes helping Chinese intellectual property go global

After years of buying licences for foreign-made medicines, Chinese biotech firms are now profiting handsomely from their own innovations.

5 Aug 2025 - 5:30AMvideocam

Visitors walk beside the booth of British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca during the third China International Supply Chain Expo in Beijing on July 17. Photo: EPA

Biomedicine: Companies

GSK to pay Hengrui US$12.5 billion for global rights to 12 drug projects

The deal would give GSK the rights to develop the drug for HRS-9821 and 11 preclinical programmes owned by Jiangsu Hengrui Pharmaceuticals.

28 Jul 2025 - 9:37PM

The research lab at the Hengrui Biomedical Industrial Park in Lianyungang in eastern China’s Jiangsu province on December 13, 2021. Photo: Getty Images.

Indonesia

Is Indonesia a ‘guinea pig’ in Bill Gates-backed TB vaccine trial?

The controversy began after President Prabowo Subianto said that Bill Gates was developing a tuberculosis vaccine to be tested in Indonesia.

15 May 2025 - 6:08PM

United States

FDA approves GSK vaccine to combat meningococcal infections

Meningococcal infections can lead to severe, sometimes deadly, bloodstream infections, and severe swelling in the brain and spinal cord.

15 Feb 2025 - 10:25PM

Medicine

WHO recommends malaria vaccine for children, to be rolled out next year

The vaccine, developed in the UK, will become available to countries by mid-2024 and doses will cost between US$2 and US$4, said WHO chief Tedros Adhanom Ghebreyesus on Monday.

3 Oct 2023 - 2:27AMvideocam

A nurse fills a syringe with malaria vaccine at the Lumumba Sub-County hospital in Kisumu, Kenya. Photo: Reuters

Coronavirus pandemic

This man says he can beat Covid-19 with nasal sprays, not needles

Marty Moore, founder of Meissa Vaccines, says nasal sprays could be the future of the fight against Covid-19 and its variants by building better protection where the battle begins.

4 Jun 2022 - 5:39AM

Marty Moore, the relentlessly upbeat founder of Meissa Vaccines Inc


CREDIT: Bloomberg Businessweek

Coronavirus pandemic